8
B.P. Jarman, B.K. Nicholson / Journal of Organometallic Chemistry 702 (2012) 1e9
10.5 Hz, H3), 4.69 (dd, 1H, JH1,H2 8.8 Hz, JH2,H3 10.5 Hz, H2), 4.06 (m,
1H, H5), 3.81 (dd, 1H, JH5,H6b 7.5 Hz JH6a,H6b 11.4 Hz, H6b), 3.65 (dd,
1H, JH5,H6a 5.2 Hz, JH6a,H6b 11.4 Hz, H6a), 2.24, 1.90, 1.87, 1.69 (s, 12H,
d 170.8, 170.4, 169.9, 169.7 (C]O), 86.9 (d,
JC1,P 4.9 Hz, C1), 74.2 (C5), 70.7 (C3), 70.5 (C2), 67.3 (C4), 61.4 (C6),
(4ꢂ CH3) ppm. 31P NMR:
d 52.8 ppm. Anal. Calcd for
C39H37NO11PSAu (955.72): C, 49.01; H, 3.90; N, 1.47. Found: C,
49.04; H, 4.24; N, 1.53. ESI-MS: m/z: 978.141 (strong, [M þ Na]þ,
calc. 978.138), 956.159 (weak, [M þ H]þ, calc. 956.156), 1933.289
(weak, [2M þ Na]þ, calc. 1933.287).
4ꢂ OAc) ppm. 13C NMR:
21.6, 20.8, 20.7, 20.6 (4ꢂ CH3) ppm. 31P NMR:
d 60.3 ppm. Anal.
Calcd for C32H33NO9PCl2Au (874.452): C, 43.95; H, 3.80; N, 1.60.
Found: C, 44.10; H, 3.85; N, 1.84. ESI-MS: m/z: 838.123 (strong,
[M ꢁ Cl]þ, calc. 838.124), 896.083 (weak, [M þ Na]þ, calc. 896.083),
947.187 (weak, [M þ NMe4]þ, calc. 947.191).
4.8. Preparation of {2-[C6H4(S)CO2]AuC6H4}Ph2P]NeR (R ¼ per-
O-acetyl galacosyl) (8b)
Similarly C,N-cycloaurated 6b (50 mg, 0.057 mmol), thiosalicylic
acid (8.8 mg, 0.057 mmol) and Ag2O (67.2 mg, 0.29 mmol) in CH2Cl2
(10 mL) gave 8b (50.4 mg, 93%).
4.5. Preparation of (2-Cl2AuC6H4)Ph2P]NeR (R ¼ per-O-acetyl
arabinosyl) (6c)
1H NMR:
d 8.16 (m, 1H, arom.), 8.06e7.05 (m, 17H, arom.), 5.82
(dd, 1H, JH1,H2 8.6 Hz, J1,P 19.1 Hz, H1), 5.25 (dd, 1H, JH4,H5 1.4 Hz,
JH3,H4 3.4 Hz, H4), 5.06 (dd, 1H, JH3,H4 3.4 Hz, JH2,H3 10.4 Hz, H3), 4.61
(dd, 1H, JH1,H2 8.6 Hz, JH2,H3 10.4 Hz, H2), 4.23 (ddd, 1H, JH4,H5 1.4 Hz,
JH5,H6b 4.9 Hz, JH5,H6a 7.6 Hz, H5), 3.81 (dd, 1H, JH5,H6a 7.6 Hz, JH6a,H6b
11.4 Hz, H6a), 3.69 (dd, 1H, JH5,H6b 4.9 Hz, JH6a,H6b 11.4 Hz, H6b), 1.89,
Similarly 6c was made using the same method as 6a, with the
sugar azide 2c (200 mg, 0.664 mmol), diphosphine 4 (240 mg,
0.332 mmol) and [NMe4][AuCl4] (274 mg, 0.664 mmol). Work up
gave 6c (456 mg, 86%). Crystals suitable for X-ray diffraction were
grown by cooling a CH2Cl2/hexane solution of 6c.
1.82, 1.69, 1.67 (4s, 12H, 4ꢂ OAc) ppm. 13C NMR:
d 170.5, 170.4,
1H NMR:
d
8.15 (m, 1H, arom.), 7.99e7.54 (m, 9H, arom.),
169.4 ꢂ 2 (C]O), 169.4 (C]O, thiosalicylate), 84.0 (d, JC1,P 6.0 Hz,
7.42e7.25 (m, 3H, arom.), 7.04 (m, 1H, arom.), 6.06 (b, 1H, H1) 5.13
(dd, 1H, JH4,H5 1.7 Hz, JH3,H4 3.5 Hz, H4), 4.96 (dd, 1H, JH3,H4 3.5 Hz,
JH2,H3 10.3 Hz, H3), 4.73 (b, 1H, H2), 3.76 (mm, 2H, H5a, H5b), 2.20,
C1), 74.1 (C5), 71.0 (C2), 70.9 (C3), 67.0 (C4), 61.8 (C6), 20.8, 20.7,
20.6, 20.5 (4ꢂ CH3) ppm. 31P NMR:
d 51.7 ppm. Anal. Calcd for
C39H37NO11PSAu (955.72): C, 49.01; H, 3.90; N,1.47. Found: C, 49.14;
H, 3.98; N, 1.56. ESI-MS: m/z: 978.140 (strong, [M þ Na]þ, calc.
978.138), 956.160 (weak, [M þ H]þ, calc. 956.156).
1.89, 1.72 (s, 9H, 3ꢂ OAc) ppm. 13C NMR:
d 170.3, 170.1, 169.5 (C]O),
88.7 (d, JC1,P 5.2 Hz, C1), 70.4 (C3), 68.7 (C2), 67.7 (C4), 65.9 (C5),
21.0, 20.8, 20.7 (3ꢂ CH3) ppm. 31P NMR:
d 60.6 ppm. Anal. Calcd for
C29H29NO7PCl2Au (802.389): C, 43.41; H, 3.64; N, 1.75. Found: C,
43.63; H, 3.91; N, 1.83. ESI-MS: m/z: 766.106 (strong, [M ꢁ Cl]þ, calc.
766.103), 1569.178 (weak, [2M ꢁ Cl]þ, calc. 1569.174).
4.9. X-ray crystallography
X-ray crystallography data is summarised in Table 1. Intensity
data and unit cell dimensions were collected on a Bruker APEX II
CCD diffractometer. Structures were solved by the direct methods
option of SHELXS97 [39]. All non-hydrogen atoms were either
initially located or found in subsequent difference maps. Full-
matrix least-squares refinement (SHELXL97 [40]) was based on
4.6. Preparation of [(2-Cl(PPh3)AuC6H4)Ph2P]NeR]$PF6 (R ¼ per-
O-acetyl glucosyl) (7a$PF6)
The C,N-cycloaurated compound 6a (50 mg, 0.0572 mmol), PPh3
(15.0 mg, 0.0572 mmol) and [NH4][PF6] (9.3 mg, 0.0572 mmol)
were suspended in dry CH2Cl2 (10 mL) under N2 and stirred for 4 h.
The mixture was filtered through Celite and addition of petroleum
spirits to the filtrate gave 7a$PF6 (47.4 mg, 67%).
2
Fo with all non-hydrogen atoms anisotropic, unless otherwise
stated. Hydrogen atoms were refined using a riding model. All
calculations were carried out by the SHELXL97 suite of programs
[40] and were run under WinGX [41]. Crystal structure graphics
1H NMR:
d 8.28 (m 1H, arom.), 7.95e7.21 (m, 26H, arom.), 6.82
(m 1H, arom.), 6.66 (m 1H, arom.), 6.12 (t, 1H, H2), 5.13 (t, 1H, H4),
4.99 (t, 1H, H3), 4.61 (bd, 1H, H6b), 4.12 (m, 1H, H1), 3.85 (bd, 1H,
H6a), 3.3.36 (bm, 1H, H5), 1.97, 1.94, 1.89, 1.77 (s, 12H, 4ꢂ OAc) ppm.
Table 1
Crystal data and refinement details.
13C NMR:
d
170.6 ꢂ 2, 170.3, 169.3 (C]O), 87.1 (C1), 73.2 (C5), 72.9
(1a)
(6a)
(6c)
Formula
C32H34NO9P
C32H33NO9PCl2Au
2CH2Cl2
1044.28
89(2)
Monoclinic
P21
9.1905(2)
12.6953(3)
17.4863(4)
99.486(1)
2012.34(8)
2
C29H29NO7PCl2Au
CHCl3$1/2C6H14
1929.64
89(2)
Monoclinic
P21
13.4315(5)
13.4103(4)
20.9413(7)
90.785(2)
3771.6(2)
4
(C3), 72.4 (C2), 68.5 (C4), 61.2 (C6), 21.0, 20.8, 20.7, 20.6 (4ꢂ
CH3) ppm. 31P NMR:
Calcd for C50H48NO9F6P3ClAu (1246.249): C, 48.19; H, 3.88; N, 1.12.
Found: C, 48.29; H, 3.91; N, 1.26. ESI-MS: m/z: 1101.288 (strong,
[7a]þ, calc. 1101.284).
d
63.5, 37.5 (PPh3), ꢁ140.4 (PFꢁ6 ) ppm. Anal.
Mr
T(K)
Crystal system
Space group
a (Å)
607.57
83(2)
Monoclinic
P21
8.6161(8)
9.9944 (10)
18.1458(18)
90.705(1)
1562.5(3)
2
b (Å)
c (Å)
4.7. Preparation of {2-[C6H4(S)CO2]AuC6H4}Ph2P]NeR (R ¼ per-
O-acetyl glucosyl) (8a)
b
(deg)
V (Å3)
Z
r
The C,N-cycloaurated compound 6a (50 mg, 0.057 mmol) and
thiosalicylic acid (8.8 mg, 0.057 mmol) were dissolved in CH2Cl2
(10 mL). Ag2O (67.2 mg, 0.29 mmol) was added and the suspension
stirred for 1 h, protected from light. The suspension was filtered
through Celite and the solvent removed from the filtrate under
vacuum. The residue was recrystallised from CHCl3 and petroleum
spirits to give 8a (48.0 mg, 88%).
(g cmꢁ3
)
)
1.291
0.142
1.723
4.145
1.699
4.343
m
(mmꢁ1
Size (mm3)
F (000)
0.66 ꢂ 0.24 ꢂ 0.13 0.49 ꢂ 0.29 ꢂ 0.23 0.70 ꢂ 0.41 ꢂ 0.10
640
34.8
32710
0.982, 0.912
12240(0.031)
1032
28.0
32579
0.450, 0.296
9497(0.029)
1908
30.7
101907
0.433, 0.193
23064(0.058)
qmax (deg)
Refln collected
Tmax, min
Unique reflns
(Rint
1H NMR:
d 8.16e7.20 (m, 18H, arom.), 5.78 (dd, 1H, J1,2 8.7 Hz, J1,P
)
21.2 Hz, H1), 5.13 (t, 1H, H3), 4.25 (m, 1H, H4), 4.17 (m, 1H, H2), 3.98
(m, 1H, H6b), 3.92 (m, 1H, H5), 3.68 (dd, 1H, H6a), 1.95, 1.93, 1.81,
d 170.3, 170.2, 169.8, 169.7
(C]O), 169.5 (C]O, thiosalicylate), 83.8 (d, JC1,P 6.5 Hz, C1), 74.6
R1 [I > 2
s
(I)]
0.0357
0.0906
1.028
0.0431
0.1122
1.134
0.053(7)
þ2.35/ꢁ2.94
0.0594
0.1675
1.035
wR2 (all data)
GOF on F2
1.57 (4s, 12H, 4ꢂ OAc) ppm. 13C NMR:
Flack parameter 0.02(4)
ꢁ0.011(7)
Final
D
e (e Åꢁ3
)
þ0.44/ꢁ0.23
þ8.94/ꢁ2.74
(C5), 73.1 (C2), 72.8 (C3), 68.4 (C4), 62.4 (C6), 20.9, 20.7, 20.7, 20.3